GlobalData on MSN6d
J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
The request is based on findings from the Phase III ASTRO study, which achieved the primary endpoint of clinical remission at ...
Medical Xpress9d
Clinical guideline for moderate-to-severe ulcerative colitis released
"Since the first biologic treatment for ulcerative colitis was introduced in 2005, 11 advanced therapies have become ...
Medscape7d
Health Maintenance in Ulcerative Colitis: 5 Things to Know
Addressing all aspects of healthcare maintenance in ulcerative colitis (UC) — one of two major types of ... Patients on ...
Daily2d
First American Gastroenterological Association living guideline for moderate-to-severe ulcerative colitis
The American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of ...
Johnson & Johnson Submits SBLA Seeking Approval Of TREMFYA In Ulcerative Colitis
Johnson & Johnson (JNJ) announced the submission of a supplemental Biologics License Application to the FDA seeking approval of a ...
Verywell Health on MSN14d
4 Types of Biologics Used for Ulcerative Colitis
Biologics work by targeting proteins that cause inflammation in ulcerative colitis. As a result, certain biologics help ...
MyChesCo on MSN2d
Johnson & Johnson Advances Ulcerative Colitis Treatment with FDA Filing for TREMFYA® Subcutaneous Regimen
SPRING HOUSE, PA – Johnson & Johnson (NYSE: JNJ) has submitted a supplemental Biologics License Application (sBLA) to the U.S ...
Armed robbery in Revesby9d
AGA Releases Guideline for Severe Ulcerative Colitis
The American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of ...
Pharmabiz3d
Johnson & Johnson seeks US FDA approval for subcutaneous induction regimen of Tremfya in ulcerative colitis
Johnson & Johnson seeks US FDA approval for subcutaneous induction regimen of Tremfya in ulcerative colitis: Spring House, Pennsylvania Monday, November 25, 2024, 11:00 Hrs [IST] ...